CAPP3: a randomized dose finding non inferiority study of aspirin to prevent cancer in Lynch Syndrome

Professor Finlay Macrae

The Royal Melbourne Hospital (VIC)

$290,340.50

2016 – 2018

‍

The Research

A trial to establish whether lower doses of aspirin are equally effective for cancer prevention making public health messages uniform across cardiovascular disease and cancer.